Show simple item record

dc.contributor.authorKristinsson, Sigurdur Yngvi
dc.contributor.authorLandgren, Ola
dc.date.accessioned2013-08-29T11:30:53Z
dc.date.available2013-08-29T11:30:53Z
dc.date.issued2012
dc.date.submitted2013-08-29
dc.identifier.citationExpert Rev Anticancer Ther 2012, 12(3):291-4en_GB
dc.identifier.issn1744-8328
dc.identifier.pmid22369320
dc.identifier.doi10.1586/era.11.214
dc.identifier.urihttp://hdl.handle.net/2336/300233
dc.descriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links field.en_GB
dc.language.isoenen
dc.relation.urlhttp://dx.doi.org/10.1586/era.11.214en_GB
dc.relation.urlhttp://www.expert-reviews.com/doi/pdf/10.1586/era.11.214en_GB
dc.rightsArchived with thanks to Expert review of anticancer therapyen_GB
dc.subject.meshAntineoplastic Agentsen_GB
dc.subject.meshAspirinen_GB
dc.subject.meshFibrinolytic Agentsen_GB
dc.subject.meshHeparin, Low-Molecular-Weighten_GB
dc.subject.meshHumansen_GB
dc.subject.meshImmunomodulationen_GB
dc.subject.meshMultiple Myelomaen_GB
dc.subject.meshPractice Guidelines as Topicen_GB
dc.subject.meshRandomized Controlled Trials as Topicen_GB
dc.subject.meshRisk Adjustmenten_GB
dc.subject.meshSecondary Preventionen_GB
dc.subject.meshThalidomideen_GB
dc.subject.meshVenous Thromboembolismen_GB
dc.subject.meshWarfarinen_GB
dc.titleThromboprophylaxis in multiple myeloma: is the evidence there?en
dc.typeArticleen
dc.identifier.journalExpert review of anticancer therapyen_GB
dc.rights.accessOpen Access - Opinn aðganguren


This item appears in the following Collection(s)

Show simple item record